BIOMARIN PHARMACEUTICAL INC (BMRN) Institutional Ownership and Insiders Activity
BIOMARIN PHARMACEUTICAL INC (BMRN) is widely held by institutional investors, with 548 firms reporting positions valued at approximately $11.92B based on SEC Form 13F filings for the quarter ended June 30, 2026.
Blackrock, Inc. is the largest disclosed holder, reporting approximately $1.17B in BMRN holdings in its latest filing.
Recent insider activity includes 2 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
548
Total Reported Value
$11.92B
Largest Holder
Blackrock, Inc.
Largest Position
$1.17B
Insider Transactions (90d)
2
Latest Filing Quarter
Q2 2026
New Institutional Positions
90
Funds Exiting Positions
94
Top Institutional Owners
View all- Blackrock, Inc.$1.17B
- Banque Cantonale Vaudoise$916.00M
- Dodge & Cox Stock Fund$849.43M
- Primecap Management Co/Ca/$811.96M
- Vanguard Capital Management Llc$500.31M
BMRN News
All news- Palo Alto Investors Q2 2026 Portfolio Changes: Major Buys and Minor Sells in Biotech Focus
Aug 22, 2026 · valut.ai
- Investor Ab Portfolio Analysis: Q2 2026 Focus on NASDAQ Inc and Micron Technology
Aug 17, 2026 · valut.ai
- Eagle Health Investments Lp: Significant Stock Purchases & Sales in Q2 2026
Aug 11, 2026 · valut.ai
Related BMRN Institutional Insights:
- BMRN 13F Institutional Holders
- BMRN Top Institutional Shareholders
- BMRN Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- BMRN Insider Trading & SEC Form 4 Activity
- BMRN Articles
- Top Institutional Investor Stock Rankings